Clinical Outcomes of an ApoE Genotype-Guided Lipid-Lowering Strategy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.

Han S, Zhang Y, Wang Z, Kong F, Xie J

Open source

DOI
10.2147/pgpm.s608221
Published
2026
Container
Pharmacogenomics and personalized medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/pgpm.s608221,
  title = {Clinical Outcomes of an ApoE Genotype-Guided Lipid-Lowering Strategy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.},
  author = {Han S and Zhang Y and Wang Z and Kong F and Xie J},
  year = {2026},
  journal = {Pharmacogenomics and personalized medicine},
  doi = {10.2147/pgpm.s608221},
  url = {https://doi.org/10.2147/pgpm.s608221}
}

RIS

TY  - JOUR
TI  - Clinical Outcomes of an ApoE Genotype-Guided Lipid-Lowering Strategy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.
AU  - Han S
AU  - Zhang Y
AU  - Wang Z
AU  - Kong F
AU  - Xie J
PY  - 2026
JO  - Pharmacogenomics and personalized medicine
DO  - 10.2147/pgpm.s608221
UR  - https://doi.org/10.2147/pgpm.s608221
ER  - 

APA

S, H., Y, Z., Z, W., F, K., & J, X. (2026). Clinical Outcomes of an ApoE Genotype-Guided Lipid-Lowering Strategy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.. Pharmacogenomics and personalized medicine. https://doi.org/10.2147/pgpm.s608221

Source records